ERBB2 and breast carcinoma: Recent studies have revealed several intrinsic subtypes of breast cancer according to the expression profiling, i.e., luminal A, luminal B, HER-2 enriched, basal-like, and normal-like subtypes which are useful to guide more precise treatments and to possibly predict relapse and survival [8, 9].